{"nct_id":"NCT01890265","title":"Evaluate the Safety and Efficacy of FG-3019 (Pamrevlumab) in Participants With Idiopathic Pulmonary Fibrosis (IPF)","status":"COMPLETED","status_verified_date":"2020-08","start_date":"2013-07-30","start_date_type":"ACTUAL","primary_completion_date":"2017-11-16","primary_completion_date_type":"ACTUAL","completion_date":"2017-11-16","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["FGEN"]}